MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predictors of dementia in Parkinson’s disease: A population-based cohort study

A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

Meeting: 2016 International Congress

Abstract Number: 1422

Keywords: Dementia

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate and describe characteristics of Parkinson’s disease (PD) patients who develop dementia during follow-up in a longitudinal study.

Background: Important non-motor features of PD are cognitive decline and dementia. Except for age and severity of PD symptoms being associated with cognitive symptom progression, course and severity of cognitive decline is variable and rather unpredictable.

Methods: A longitudinal cohort of 246 incident PD patients from a population-based study, was followed for 5 years to on average 7.5 years of PD duration. We assessed differences in PD symptom progression and lifestyle factors in patients who developed dementia after baseline (MMSE≤24) versus those who did not, using t-tests, chi-square tests, and Cox proportional hazards regression. We conducted repeated measurement analyses of progression using the UPDRS, GDS, and lifestyle data.

Results: Overall, 34 patients developed dementia during follow-up. At baseline these patients were slightly older, more often of non-European ancestry, and took more levodopa (mean 376.2 mg/day (SD 245.9) vs 267.6 (SD 267.6)). Though their scores were similar at baseline, across follow-up, progression of depressive (GDS) and motor symptoms (UPDRS-III) mirrored cognitive decline: those who developed dementia experienced a mean change in GDS of 2.8 (SD 3.6) points compared with 0.69 (SD 3.0) points in non-demented patients, and 22.1 (SD 17.8) points on the UPDRS-III vs 9.4 (SD 11.6) points. The postural instability gait difficulty (PIGD) subtype was more common in those who developed dementia and in time to dementia analysis, the tremor dominant (TD) subtype was protective against dementia (Hazard Ratio HR=0.22, 95% CI=0.05-0.94, p=0.04); the TD subtype was also protective in time to all-cause mortality (HR=0.66, 95% CI=0.43, 1.00, p=0.05).

Conclusions: Our data support previous research that indicated correlations between motor and non-motor symptom severity such that decline is experienced in multiple domains simultaneously.

To cite this abstract in AMA style:

A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz. Predictors of dementia in Parkinson’s disease: A population-based cohort study [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/predictors-of-dementia-in-parkinsons-disease-a-population-based-cohort-study/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/predictors-of-dementia-in-parkinsons-disease-a-population-based-cohort-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley